Podium to Practice: SABCS® 2025 – EMBER-3
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Studies / Trials Discussed
GS3-08 – Imlunestrant with or without abemaciclib in advanced breast cancer (ABC): Updated efficacy results from the phase 3 EMBER-3 trial
Studies/trials discussed:
GS3-08 – Imlunestrant with or without abemaciclib in advanced breast cancer (ABC): Updated efficacy results from the phase 3 EMBER-3 trial
199 Bay Street #4000
Toronto, ON M5L 1A9
©2026 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement. Cookies Policy.
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.